Experimental Therapeutics, Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA.
Neuropsychopharmacology. 2010 Jun;35(7):1415-22. doi: 10.1038/npp.2010.24. Epub 2010 Mar 10.
Pregenual anterior cingulate cortex (pgACC) hyperactivity differentiates treatment responders from non-responders to various pharmacological antidepressant interventions, including ketamine, an N-methyl-D-aspartate receptor antagonist. Evidence of pgACC hyperactivition during non-emotional working memory tasks in patients with major depressive disorder (MDD) highlights the importance of this region for processing both emotionally salient and cognitive stimuli. However, it is unclear whether pgACC activity might serve as a potential biomarker of antidepressant response during working memory tasks as well, in line with previous research with emotionally arousing tasks. This study tested the hypothesis that during the N-back task, a widely used working memory paradigm, low pretreatment pgACC activity, as well as coherence between the pgACC and the amygdala, would be correlated with the clinical improvement after ketamine. Magnetoencephalography (MEG) recordings were obtained from 15 drug-free patients with MDD during working memory performance 1 to 3 days before receiving a single ketamine infusion. Functional activation patterns were analyzed using advanced MEG source analysis. Source coherence analyses were conducted to quantify the degree of long-range functional connectivity between the pgACC and the amygdala. Patients who showed the least engagement of the pgACC in response to increased working memory load showed the greatest symptomatic improvement within 4 h of ketamine administration (r=0.82, p=0.0002, false discovery rate (FDR) <0.05). Pretreatment functional connectivity between the pgACC and the left amygdala was negatively correlated with antidepressant symptom change (r=-0.73, p=0.0021, FDR <0.05).These data implicate the pgACC and its putative interaction with the amygdala in predicting antidepressant response to ketamine in a working memory task context.
背外侧前额皮质(pgACC)的活性亢进可将接受各种药物抗抑郁干预(包括 NMDA 受体拮抗剂氯胺酮)的反应者与非反应者区分开来。在患有重度抑郁症(MDD)的患者中,非情绪性工作记忆任务期间 pgACC 的过度活跃的证据强调了该区域对于处理情绪和认知刺激的重要性。然而,目前尚不清楚 pgACC 的活动是否可以作为工作记忆任务中抗抑郁反应的潜在生物标志物,这与之前的情绪刺激任务研究一致。这项研究检验了一个假设,即在 N-back 任务(一种广泛使用的工作记忆范式)中,低预处理 pgACC 活性以及 pgACC 和杏仁核之间的相干性,与氯胺酮治疗后的临床改善相关。在接受单次氯胺酮输注之前的 1 至 3 天,从 15 名未服用药物的 MDD 患者中获得了 MEG 记录。使用先进的 MEG 源分析来分析功能激活模式。进行源相干性分析以量化 pgACC 和杏仁核之间长程功能连接的程度。在对增加的工作记忆负荷的反应中,pgACC 参与度最低的患者在接受氯胺酮给药后 4 小时内表现出最大的症状改善(r=0.82,p=0.0002,错误发现率(FDR)<0.05)。pgACC 和左侧杏仁核之间的预处理功能连接与抗抑郁症状变化呈负相关(r=-0.73,p=0.0021,FDR <0.05)。这些数据表明,pgACC 及其与杏仁核的潜在相互作用可预测在工作记忆任务背景下氯胺酮对抗抑郁反应。